Search
-
More than one in two feel their country needs to do more on its infrastructure needs
The 2024 Global Infrastructure Report from Ipsos and the Global Infrastructure Investor Association (GIIA).
-
Food
Obesity drugs, private-label foods and shifting social patterns are disrupting America’s food landscape. What the Future lays out how food makers to packaging companies to appliance makers can thrive in these changes.
-
How obesity drugs, politics and climate change are shaping the future of food
In the six years since our first Food issue, several of What the Future’s future scenarios have come to fruition. Editor Matt Carmichael looks at those shifts and others that will shape the decade to come, from obesity medications to politicization.
-
Shifts: Personalized nutrition, food politics and regenerative architecture
Ipsos Strategy3’s Trevor Sudano sets the table for the issue with a look at three key forces reshaping Americans’ food and drink habits: personalization, politicization and sustainability.
-
How food companies can meet diners’ needs everywhere
Ipsos’ Anne Hunter explains how food manufacturers can maximize sales in every environment by understanding the distinct needs of consumers and professional food buyers.
-
Why diverse approaches and collaboration are vital for future protein needs
As demand for protein expands, brands will need to innovate quickly and strategically to meet these needs without overly relying on any one innovation, says Cargill’s Florian Schattenmann.
-
How social listening can inform better research and development
New AI tools can help brands keep up with fast-moving social conversations to spot industry signals and trends to steer smarter innovation, says Ipsos’ Joe Lonek.
-
Why GLP-1 drugs’ impact on food will be more evolution than revolution
GLP-1s could revolutionize Americans’ diets, but brands and businesses need to consider these treatments in context, according to Erin Lash, director of consumer sector equity research for Morningstar.
-
How brands can get more context about the impact of weight-loss drugs
GLP-1s have the potential to transform not just Americans’ diets, but their broader lifestyles and cross-category consumption habits. To get the complete picture, brands need human-centric research, says Ipsos’ Alexandra Stiver.
-
How private-label brands are redefining value for food consumers and retailers
Better quality and differentiated benefits have driven cost-conscious consumers to more private-label brands, but the bigger opportunity is what comes next, according to TreeHouse Foods’ Amit Philip.